Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
Domenica Rubino, Niclas Abrahamsson, Melanie Jane Davies, Dan Hesse, Frank L. Greenway, Camilla Jensen, Ildiko Lingvay, Ofri Mosenzon, Julio Rosenstock, Miguel A. Rubio, Gottfried Rudofsky, Sayeh Tadayon, Thomas A. Wadden, Dror Dicker, STEP 4 Investigators, M. Friberg, Anders Mikael Sjödin, Gabriella Segal, Muhammad Sabbah, Yael Sofer, Victor Vishlitzky, Eelco W. Meesters, Mirelle Serlie, Arianne C. van Bon, Helena Cardoso, and 63 more
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1001/jama.2021.3224
- Published
- Mar 23, 2021
- Venue
- JAMA
- DOI
- 10.1001/jama.2021.3224
- PubMed
- 33755728
- Categories
- Pharmacology and Obesity Treatment
- Provenance
- openalex